Clinical trials
Phase 3 Cardiomyopathies trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 5 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Intellia Therapeutics | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Mallinckrodt | 1 |
| University Hospital, Limoges | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 11 |
| Amyloidosis | 7 |
| Amyloidosis, Familial | 3 |
| Alzheimer Disease | 2 |
| Amyloid Neuropathies, Familial | 2 |
| Heart Failure | 2 |
| Acute Lung Injury | 1 |
| Amyloid Neuropathies | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Heart Defects, Congenital | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.